Data layers Raw facts Calculated Model prediction AI interpretation

Company Overview

Stock NameHuasheng Intl
Stock Code01323
Company Full NameTo be extracted
IndustryIndustrial Goods
Principal Activities本集團的主營業務是產銷家居及醫療用途的一次性衛生用品,產品主要包括醫療用廢物袋、一般廢物袋、一次性膜袋及圍裙。
Listing Date2011-01-13
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省惠州市
Business Address (Hong Kong)香港干諾道中168–200號信德中心西座37樓3702室
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitewww.newtreegroupholdings.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism Mechanism A
Offer PriceHK$ 1.95 / shares
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2011-01-05 to 2011-01-05
Global Offering Shares190,000,000 shares
HK Public Offer Shares (Initial)19,000,000 shares (10.0%)
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)171,000,000 shares (90.0%)
Offer Ratio~10.0%
Total Shares Post-IPO666,666,000 shares
Greenshoe (Over-allotment Option)Yes
Stabilizing Manager (Greenshoe)To be extracted
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionYes
Total Global Offering SizeHK$ 370,500,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 157.3M
Est. Threshold HK$ 9.69B
Analysis Result HK market cap below threshold, need +6062%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss Status截至二零一零年三月三十一日止年度盈利約78,900,000港元
Period-End Cash Balance9,237,000港元
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted

Financial Data

Unit: '000 HKD
Income Statement
Item 2008-032009-032010-032010-06
Revenue 282,080311,607427,116113,706
Cost of sales -219,863-247,268-334,299-89,009
Gross profit 62,21764,33992,81724,697
Other income and gains, net 4,6281,0347,4972,295
Selling and distribution expenses -14,233-10,827-11,747-2,916
Administrative expenses -9,463-10,680-8,619-2,844
Operating profit 43,14943,86679,94817,486
Profit before tax 43,14943,86679,94817,486
Income tax expense 0-335-1,004-540
Profit for the year 43,14943,53178,94416,946
Profit attributable to owners 43,14943,53178,94416,946
Balance Sheet
Item 2008-032009-032010-032010-06
Cash and cash equivalents 7,98017,8619,23732,982
Trade and bills receivables 50,28732,942124,75482,163
Inventories 69,43433,60743,77334,965
Total current assets 139,524141,415333,895150,308
Total assets 206,235254,965382,682197,954
Total current liabilities 100,279108,069156,62994,800
Total liabilities 100,279108,069156,62994,800
Total equity 105,956146,896226,053103,154
Equity attributable to owners 105,956146,896226,053103,154
Cash Flow Statement
Item 2008-032009-032010-032010-06
Net cash from operating activities 4,797102,60621,66447,039
Net cash from investing activities -14,035-98,666-34,658-24,528
Net cash from financing activities 5,5015,9144,3611,242
Net increase in cash -3,7379,854-8,63323,753
Depreciation of PP&E 4,5115,1485,3441,353
Amortisation of intangible assets 18419719750
Purchase of PP&E -1,443-235-1,715-99
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
First Day CloseHK$ 1.76
First Day OpenHK$ 1.93
First Day Change-9.74%
First Day Volume83816000.0
First Day Turnover148854000.0
Use of Proceeds
1、約142,800,000港元(50%)將用于(i)建造在中國的新生產設施(10%),以及(ii)為該新生產設施購買設備,以制造供應中國市場的一次性醫療用品(40%); 2、約28,600,000港元(10%)將用于收購一幅劃定建造中國新生產設施的土地的土地使用權; 3、約20,000,000港元(7%)將用于對進口歸類為第二類醫療器械的醫療產品于中國市場的分銷渠道的推廣發展及提供營運資金; 4、約22,800,000港元(8%)將用于提升及添置惠州廠房生產設施,以生產醫療一次性衛生用品; 5、約28,600,000港元(10%)將用于市場推廣開支,擴大在法國、德國、意大利及瑞典等部分歐洲國家的銷售; 6、約28,600,000港元(10%)將用于市場推廣開支,擴大在美國市場的銷售; 7、約14,200,000港元(5%)將撥作額外營運資金、策略投資及其他一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
建银国际金融有限公司 CE AJO225
Overall Coordinators (1)
国泰君安证券(香港)有限公司 CE ABY236
Joint Bookrunners (1)
国泰君安证券(香港)有限公司 CE ABY236
Joint Lead Managers (1)
国泰君安证券(香港)有限公司 CE ABY236

Cornerstone Investors

This stock has no cornerstone investors.

Directors & Management

PositionChinese nameEnglish Name
Chairman覃通衡—
Company Secretary陳紹源—
No director data available.

Major Shareholders

Major Shareholders & Holdings覃氏家族信託通過Golden Realm及Able Bright持有476,666,000股,佔緊隨全球發售後已發行股份約71.5%。
About this page

This page shows Huasheng Intl (01323) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect